Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 4, 2006, Pages 573-583

  Cheung, T K ^a   Lai, C L ^a   Wong, B C Y ^a   Fung, J ^a   Yuen, M F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CANCER SURVIVAL; CHINESE; CLINICAL FEATURE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HONG KONG; HUMAN; JAUNDICE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SCREENING; VIROLOGY; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; HEPATITIS B, CHRONIC; HONG KONG; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 33746424431     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03029.x     Document Type: Article

References (19)

1. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. Cancer 2004; 101: 3-27.
2. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001; 2: 533-43.
3. Lai CL, Locarnini S, (ed). Hepatitis B virus. London: International Medical Press, 2002.
4. Hong Kong Cancer Registry. Cancer Incidence and Mortality in Hong Kong. Hong Kong: Hospital Authority, 2000.
5. Lai CL, Lam KC, Wong KP, Wu PC, Todd D. Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer 1981; 47: 2746-55.
6. Bialecki ES, Di Bisceglie AM. Clinical presentation and natural course of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2005; 17: 485-9.
7. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31: 330-5.
8. Leung TW, Tang AM, Zee B, et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 2002; 94: 1760-9.
9. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 918-28.
10. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: Hepatology 1998; 28: 751-5.
11. Levy I, Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002; 50: 881-5.
12. Ueno S, Tanabe G, Sako K, et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001; 34: 529-34.
13. Farinati F, Rinaldi M, Gianni S, Naccarato R. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 2000; 89: 2266-73.
14. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005; 19: 3-23.
15. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF, Jr. International trends and patterns of primary liver cancer. Int J Cancer 2001; 94: 290-6.
16. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-74.
17. Ohkubo K, Kato Y, Ichikawa T, et al. Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer 2002; 94: 2663-8.
18. Marrero JA, Fontana RJ, Barrat A, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 2005; 41: 707-16.
19. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.